Ειδήσεις: PHARMACEUTICALS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 23:58 investing.com

ORIC Pharmaceuticals stock tumbles 27% after trial update

ORIC Pharmaceuticals stock drop clinical trial update 27% decline investor reaction regulatory concerns

31/03 19:28 yahoo.com

Why Agios Pharmaceuticals Stock Is Up More Than 21% Today

Agios Pharmaceuticals stock surge biotech oncology pipeline clinical trial partnership

31/03 19:05 yahoo.com

Johnson & Johnson (JNJ) Benefits from Growth Pipeline and Strength Across Key Therapeutic Areas

Johnson & Johnson growth pipeline therapeutic diversification pharmaceuticals medical devices consumer health

31/03 18:06 yahoo.com

Cantor Fitzgerald Cuts PT on Apellis Pharmaceuticals (APLS) to $31 From $35 – Here’s Why

Cantor Fitzgerald Apellis Pharmaceuticals price target drug pipeline regulatory hurdles financial outlook

31/03 15:01 investing.com

Agios stock surges on FDA path for mitapivat approval

Agios Pharmaceuticals mitapivat FDA approval stock surge rare metabolic disorders investor confidence

31/03 14:29 statnews.com

STAT+: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal

Eli Lilly Centessa Pharmaceuticals acquisition narcolepsy drug $6.3B premium

31/03 12:00 defenseworld.net

Boston Common Asset Management LLC Sells 20,952 Shares of Vertex Pharmaceuticals Incorporated $VRTX

Vertex Pharmaceuticals Boston Common Asset Management 13F filing institutional investor share sale Mitsubishi UFJ Asset Management

31/03 10:30 defenseworld.net

Eli Lilly and Company (NYSE:LLY) Given New $1,163.00 Price Target at Guggenheim

Eli Lilly price target Guggenheim JPMorgan buy rating stock analysis

31/03 09:31 defenseworld.net

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $9.00 at Bank of America

Rocket Pharmaceuticals price target Bank of America Cantor Fitzgerald Morgan Stanley Goldman Sachs

31/03 09:31 defenseworld.net

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $9.00 at Bank of America

Rocket Pharmaceuticals price target Bank of America Cantor Fitzgerald Morgan Stanley Goldman Sachs

Loading...